Loading…
InterCure Ltd. is projected to rise to $1.11 by 2027, a +15% move from its current price of $0.97. INCR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.9329 | $0.9707 | $1.01 | +0.07% |
| Jul 14 | $0.9184 | $0.9715 | $1.03 | +0.15% |
| Jul 15 | $0.9076 | $0.9722 | $1.04 | +0.22% |
| Jul 16 | $0.8986 | $0.9729 | $1.05 | +0.30% |
| Jul 17 | $0.8909 | $0.9736 | $1.06 | +0.37% |
| Jul 18 | $0.884 | $0.9744 | $1.07 | +0.45% |
| Jul 19 | $0.8778 | $0.9751 | $1.08 | +0.53% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8778 | $0.9751 | $1.08 | +0.53% |
| Week 2 | $0.8449 | $0.9802 | $1.14 | +1.05% |
| Week 3 | $0.8214 | $0.9854 | $1.18 | +1.58% |
| Week 4 | $0.8028 | $0.9905 | $1.22 | +2.12% |
| Week 5 | $0.7872 | $0.9957 | $1.26 | +2.65% |
| Week 6 | $0.7738 | $1.00 | $1.29 | +3.19% |
| Week 7 | $0.762 | $1.01 | $1.33 | +3.73% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InterCure Ltd. (INCR) is a healthcare company focused on the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
InterCure Ltd. operates in the Healthcare sector and trades under the INCR ticker. Its current price is $1.00 with a market cap of $57.15M and it holds a rank of 4444. The stock is positioned near the lower end of its 30-day range, reflecting a near-term valuation around $1.00, with a 30-day range spanning from $0.7466 to $1.34.
A major floor 32.3% below — a decisive break under it would weaken the trend.
The nearest floor, 12.4% below — buyers have tended to step in here.
The nearest ceiling, 23.7% above — a clean break opens room to run.
A major ceiling 39.9% above — clearing it would confirm fresh momentum.
Key INCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.977 | Sell | $0.9885 | Sell |
| MA 10 | $1.03 | Sell | $1.00 | Sell |
| MA 20 | $1.00 | Sell | $1.00 | Sell |
| MA 50 | $0.9449 | Buy | $0.9584 | Buy |
| MA 100 | $0.8718 | Buy | $0.955 | Buy |
| MA 200 | $1.07 | Sell | $1.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.71 | Neutral |
| Stoch RSI (14) | 3.00 | Buy |
| CCI (20) | -34.52 | Neutral |
| Williams %R (14) | -96.97 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -11.01 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 3.03 | Buy |
| TRIX (15) | 0.41 | Buy |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 32.65 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 0.94 | Buy |
| ADX (14) | 12.57 | Neutral |
| ATR (14) | 0.04 | Info |
The near-term technical picture is bullish sentiment overall. The RSI(14) is 50, with the 50-day simple moving average at $0.9387 and the 200-day simple moving average at $1.08. Key supports and resistances stand at $0.847 and $1.20 respectively, framing a 30-day trading range of $0.7466 to $1.34.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.73 | $0.97 | $1.41 | 0% | Neutral | |
| $0.8477 | $1.11 | $1.56 | +15% | Neutral | |
| $0.8888 | $1.22 | $1.80 | +25% | Bullish | |
| $0.8124 | $1.15 | $1.77 | +19% | Neutral | |
| $0.777 | $1.14 | $1.81 | +17% | Neutral | |
| $0.9756 | $1.47 | $2.40 | +52% | Bullish | |
| $1.16 | $1.80 | $3.02 | +86% | Bullish | |
| $1.19 | $1.89 | $3.24 | +95% | Bullish | |
| $1.11 | $1.81 | $3.17 | +87% | Bullish | |
| $1.11 | $1.85 | $3.30 | +91% | Bullish | |
| $1.49 | $2.80 | $5.40 | +189% | Bullish | |
| $2.57 | $5.72 | $12.35 | +489% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.73 | $0.97 | $1.19 | +0.00% |
| August 2026 | $0.867 | $1.04 | $1.28 | +6.83% |
| September 2026 | $0.86 | $1.04 | $1.30 | +0.21% |
| October 2026 | $0.8262 | $1.01 | $1.28 | -3.08% |
| November 2026 | $0.8438 | $1.04 | $1.33 | +2.90% |
| December 2026 | $0.8799 | $1.09 | $1.41 | +5.01% |
Click any year to see its month-by-month INCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INCR to range from $0.73 to $1.41 through 2026. The $0.97 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INCR price prediction for 2027 points to an average of $1.11 (low $0.8477, high $1.56) — a potential gain of +15% on today's $0.97. Price action looks broadly range-bound.
In 2028, INCR is projected to trade between $0.8888 and $1.80, averaging $1.22 — a potential gain of +25% from today's $0.97. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
InterCure Ltd.'s 2029 outlook centres on $1.15, within a $0.8124 to $1.77 range. That is -5% versus the projected 2028 average. That marks a +19% change versus current levels. Price action looks broadly range-bound.
By 2030, INCR could reach as high as $1.81, with a base case around $1.14 and support toward $0.777 — roughly +17% from $0.97. A consolidation phase looks the most probable path here.
Expect INCR to range from $0.9756 to $2.40 through 2031. The $1.47 average target implies a +52% move from current prices. That is up +29% on the projected 2030 average. Momentum favours further upside here.
The INCR price prediction for 2032 points to an average of $1.80 (low $1.16, high $3.02) — a potential gain of +86% on today's $0.97. Buyers look set to stay in control over this stretch.
In 2033, INCR is projected to trade between $1.19 and $3.24, averaging $1.89 — a potential gain of +95% from today's $0.97. That is up +5% on the projected 2032 average. Momentum favours further upside here.
InterCure Ltd.'s 2034 outlook centres on $1.81, within a $1.11 to $3.17 range. That is -4% versus the projected 2033 average. That marks a +87% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, INCR could reach as high as $3.30, with a base case around $1.85 and support toward $1.11 — roughly +91% from $0.97. Momentum favours further upside here.
Expect INCR to range from $1.49 to $5.40 through 2040. The $2.80 average target implies a +189% move from current prices. That is up +51% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INCR price prediction for 2050 points to an average of $5.72 (low $2.57, high $12.35) — a potential gain of +489% on today's $0.97. Momentum favours further upside here.
Investing $1,000 in INCR today (≈ 1,030.927835 INCR) could be worth
$5,892.29
+$4,892.29 (+489%) by 2050 · US Dollar
Based on the average projected INCR price of $5.72 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INCRwould be worth at today's price.
$1,000 invested in INCR on Jul 10, 2025 (≈ 624.999991 INCR) would be worth
$606.25
-$393.75 (-39.4%) today · 0.61× · US Dollar
Based on a INCR entry price of $1.6 vs. today's $0.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.09 | $889.91 | -11.0% |
| 1 month ago | $0.85 | $1,141.18 | +14.1% |
| 3 months ago | $0.763 | $1,271.3 | +27.1% |
| 6 months ago | $0.986 | $983.77 | -1.6% |
| 1 year ago | $1.6 | $606.25 | -39.4% |
| All time (5.0y) ago | $6.7 | $144.78 | -85.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INCR forecast.
Our base-case forecast reaches $1.90 around 2040.
Implied market cap at $1.90: $108.59M
The multi-year forecast shows a gradual rise in average price from 2026 through 2050. In 2026 the average price is $1.00 with a min of $0.73 and a max of $1.49 (ROI 0, sentiment NEUTRAL). By 2027 the avg is $1.15 (min $0.8592, max $1.65, ROI 14.6).
The forecast accelerates in 2028 to an avg of $1.28 (min $0.9118, max $1.94, ROI 27.7) and then softens through 2029 (avg $1.19, min $0.8155, max $1.88, ROI 19) and 2030 (avg $1.17, min $0.7728, max $1.92, ROI 17). From 2031 onward the outlook strengthens, with 2031 avg $1.60 (min $1.02, max $2.71, ROI 60.4, sentiment BULLISH), 2032 avg $1.96 (min $1.21, max $3.40, ROI 96), 2033 avg $2.03 (min $1.22, max $3.61, ROI 103.2), 2034 avg $1.96 (min $1.14, max $3.57, ROI 96.1), 2035 avg $1.98 (min $1.12, max $3.67, ROI 98). The long horizon remains bullish with 2040 avg $3.09 (min $1.52, max $6.24, ROI 208.8) and 2050 avg $6.49 (min $2.92, max $14.79, ROI 549.1).
Tap a question to reveal the answer.
In 2030 the average price is forecast at $1.17, with a min of $0.7728 and a max of $1.92, and a forecasted ROI of 17. The sentiment for 2030 is NEUTRAL.
The long-term forecast shows bullish sentiment from 2031 onward, with rising averages and higher ROIs, including an average of $1.60 in 2031, $1.96 in 2032, $2.03 in 2033, $3.09 in 2040, and $6.49 in 2050, with ROIs up to 549.1. These are estimates and carry uncertainty.
Yes. The forecast for 2033 shows an average of $2.03 with a max of $3.61, and 2032 is $1.96 average, indicating the potential to surpass $2 within the horizon.
The current price is $1.00 and the market cap is $57.15M, with a market rank of 4444.
For 2040 the average price is forecast at $3.09 (min $1.52, max $6.24, ROI 208.8, sentiment BULLISH). For 2050 the average price is forecast at $6.49 (min $2.92, max $14.79, ROI 549.1, sentiment BULLISH).
InterCure Ltd. Community Discussion
0Share your InterCure Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.